Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
6 studies found for:    PF-00489791
Show Display Options
Rank Status Study
1 Completed A Dose Finding Study Of PF-00489791 In Patients With Mild To Moderate High Blood Pressure
Condition: Hypertension
Interventions: Drug: PF-00489791;   Drug: placebo
2 Completed A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy
Condition: Diabetic Nephropathies
Interventions: Drug: PF-00489791;   Drug: Placebo
3 Completed
Has Results
A Study to Estimate the Effect of CYP3A4 Inhibitors (Itraconazole, Diltiazem or Verapamil) on the Pharmacokinetics of Single Dose PF- 00489791 in Healthy Volunteers
Condition: Healthy Volunteers
Interventions: Drug: itraconazole;   Drug: diltiazem;   Drug: SR verapamil;   Drug: PF-00489791
4 Completed A Study To Compare Pregabalin/PF-00489791 Combination Versus Pregabalin Alone In Post-Herpetic Neuralgia
Condition: Postherpetic Neuralgia
Interventions: Drug: pregabalin;   Drug: pregabalin/PF-00489791;   Drug: Placebo
5 Completed PF-00489791 For The Treatment Of Raynaud's
Conditions: Raynaud's Disease;   Peripheral Vascular Disease
Intervention: Drug: PF-00489791
6 Terminated A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension
Condition: Hypertension, Pulmonary
Interventions: Drug: PF-00489791;   Drug: placebo;   Drug: sildenafil

Study has passed its completion date and status has not been verified in more than two years.